- Home
- Products
- About QI
- Mission Statement
- News
- Publications
- Contact QI
- Resources
- Locating Clinical Trials
- Florida Cancer Institute-New Hope
- National Cancer Institute
- University of South Alabama
- NCBI
- National Alliance of Breast Cancer
- National Breast Cancer Organization
- National Breast Cancer Coalition
- Young Survival Coalition
- The Mayo Clinic
- Cancer Center of John Hopkins
- Sloan Kettering Cancer Center
- Harvard Cancer Center
- Moffitt Cancer Center
- Driving Miss Darby
- Team Up! Against Cancer
As the Company’s Executive Vice-President, Barry Rooth is responsible for providing regulatory oversight of the company’s FDA-authorized study using OFA-loaded dendritic cells in patients with metastatic breast cancer. Mr. Rooth is also managing QI’s intellectual property portfolio in conjunction with the Company’s counsels. Mr. Rooth received his undergraduate degree from Indiana University in 1979, and his J.D. from Valparais University School of Law in 1982. Mr. Rooth is also a partner in the law firm of Theodoros & Rooth